 The data suggests a lasting benefit of taking aspirin. People who had taken aspirin for a period had 20 per cent lower risk of death from certain types of cancer and 35 per cent lower for gastrointestinal cancers. ‘We know from the trials of aspirin looking at heart attacks and strokes that there is a small benefit from aspirin in helping middle-aged people in terms of preventing heart attacks and strokes. That’s partly offset by the risk of stomach bleeding, but there is still some benefit. When you add in the cancer benefit on top of that it pushes things much more in favour.’
|
